Skip to main content

Table 2 Potential clinical application of m6A methylation in osteosarcoma

From: The role of m6A methylation in osteosarcoma biological processes and its potential clinical value

Source

Non-tumor samples

Tumor samples

m6A regulators

Role in

Potential application

References

Publicly datasets

17

306

METTL3, KIAA1429, HNRNPA2B1, FTO, METTL14, YTHDF2

Poor prognosis

Biomarker

[60]

Tissue microarray

65

120

METTL3, KIAA1429, HNRNPA2B1, FTO, METTL14, YTHDF2

Poor prognosis

Biomarker

[60]

Publicly datasets

80

80

METTL3 and ALKBH5

Poor prognosis

Biomarker

[61]

Clinical samples

70

70

ALKBH5

Poor prognosis

Oncogene

Biomarker

Therapeutic target

[54]

Publicly datasets

3

44

WTAP

Poor prognosis

Oncogene

Biomarker

Therapeutic target

[55]

Clinical samples

104

104

WTAP

Poor prognosis

Oncogene

Biomarker

Therapeutic target

[55]

Tissue microarray

65

120

KIAA1429

Poor prognosis

Chemotherapy resistance

Biomarker

Therapeutic target

[56]

Tissue microarray

65

120

YTHDF2

Chemotherapy resistance

Therapeutic target

[57]